Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
January 9, 2026European Heart Journal Acute Cardiovascular Care

Dual Antiplatelet Therapy Escalation and De-escalation

View Full Paper
Ask AI
Bookmark
Share

Key result

De-escalation of dual antiplatelet therapy significantly reduces bleeding events without compromising ischemic outcomes in selected patients.

Authors

AGAntonio GrecoGLGiacinto Di LeoSFSimone Finocchiaro

Discussion

Loading...

Member takes

Overview

This review highlights DAPT modulation strategies, reporting on de-escalation and escalation techniques in patients after coronary intervention, suggesting further investigation is needed.

Key Points

  • The review aims to summarize and critically analyze evidence for dual antiplatelet therapy modulation strategies and their implications for patient care.
  • Reviewed randomized trials on DAPT modulation
  • Assessed evidence on de-escalation and escalation strategies
  • Highlighted ongoing studies in the field
  • De-escalation reduces bleeding events without compromising ischemic outcomes in select patients
  • Escalation strategies lack widespread adoption due to limited support and evidence
  • Current patients are generally at a higher bleeding risk compared to thrombosis risk

Cite This Study

Greco et al. (2026) studied this question. De-escalation of dual antiplatelet therapy significantly reduces bleeding events without compromising ischemic outcomes in selected patients.

synapsesocial.com/papers/696128f244c2cd6c68456c4ahttps://doi.org/10.1093/ehjacc/zuaf173
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evolution of Dual Antiplatelet Therapy in the Era of New-Generation Drug-Eluting Stents: Balancing Ischemic and Bleeding Risks2026
  2. 2Shorter vs. Standard Duration of Dual Antiplatelet Therapy in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis2025
  3. 3Dual Antiplatelet Therapy in NSTEMI: Successfully Navigating the DAPT Dilemma2025
  4. 4Personalized Antithrombotic Therapy After Percutaneous Coronary Intervention: A Systematic Review of Risk‐Stratified Approaches2026
  5. 5Cutting-Edge Cardiology: Individualizing Antiplatelet Therapy for Optimal Acute Coronary Syndrome Outcomes2026